Mobile-health Network Solutions Inc. is a Singapore-based AI-powered digital health and telemedicine company. It operates the MaNaDr platform, a comprehensive healthcare ecosystem accessible via mobile app and website, connecting patients and providers through teleconsultations, electronic medical certificates, medication delivery, and e-commerce for healthcare products. The company offers two main segments: telemedicine and related services, and the sale of medicine and medical devices. Key features include the proprietary Health Operating System integrating AI tools like Phi GPT, which powers clinical support applications such as AI Checker for note evaluation, AI Notes for real-time documentation, and Aiko, a multilingual patient companion for medication management and preventive care. These tools enhance virtual care workflows, documentation quality, and patient engagement while prioritizing data privacy with ISO 27001 and SOC 2 certified infrastructure. Mobile-health Network Solutions Inc. supports clinicians, patients, and corporate wellness programs across Southeast Asia, with a focus on scalable, asset-light digital services. Headquartered in Singapore, it emphasizes accessible healthcare for underserved communities through technology-driven solutions.
$3.21
$0.10 (-3.17%)
EOD Jul 17, 2026
The business is unprofitable at the operating level (-112.42% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue grew 77.4%, still solid. Margins contracted 71.0pp, which offsets some of the top-line progress.
ROIC dropped from -57.95% to -505.21%, capital efficiency is deteriorating. Negative free cash flow of -$7M. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$14M
▲ +77.4% YoY
Net Income (TTM)
-$16M
▼ -385.6% YoY
Op. Margin
-112.42%
▼ -71.0pp YoY
ROIC
-505.21%
▼ -447.3pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$7M
▼ -168.6% YoY
Op. Cash Flow (TTM)
-$6M
▼ -171.5% YoY
Net Debt
-$6M
Net Cash Position
Cash & Equiv.
$7M
3Y CAGR: +75.5%
Continue Research
Mobile-Health Network Solutions (MNDR)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Mobile-Health Network Solutions scores 35/100 on Intrinsiqq's quality scorecard, weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
Mobile-Health Network Solutions scores 35 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a -112.4% operating margin and a -505.2% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh MNDR's valuation and scores 35/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.